Association of Plasma C1q/TNF-Related Protein 3 (CTRP3) in Patients with Atrial Fibrillation

Table 2

Clinical and biochemical characteristics of AF subgroups.

	Paroxysmal AF ()	Persistent AF ()	value
Age (years)			0.543
Gender male (%)	26 (46.4)	16 (84.2)	0.004
BMI (kg/m^2)			0.185
SBP (mmHg)			0.446
DBP (mmHg)			0.148
Smoking (%)	19 (33.9)	8 (42.1)	0.521
HT history (%)	33 (58.9)	11 (57.9)	0.937
HLP history (%)	31 (55.4)	10 (52.6)	0.837
DM history (%)	9 (16.1)	4 (21.1)	0.885
CHD history (%)	11 (20.0)	3 (15.8)	0.949
Anticoagulant (%)	14 (25.0)	7 (36.8)	0.321
Antiplatelet drugs (%)	12 (21.4)	3 (15.8)	0.842
Statin (%)	19 (33.9)	4 (21.1)	0.445
ACEI/ARB (%)	12 (21.4)	4 (21.1)	1.000
CCB (%)	20 (35.7)	5 (26.3)	0.453
Β blockers (%)	20 (35.7)	11 (57.9)	0.090
HbAlc (%)			0.113
Cr (μmol/l)			0.007
TC (mmol/l)			0.699
TG (mmol/l)			0.706
LDL-C (mmol/l)			0.550
HDL-C (mmol/l)			0.090
Us-CRP (mg/l)	0.78 (0.10, 23.98)	0.64 (0.04, 6.21)	0.946
NT-proBNP (pg/ml)	144.6 (6.43, 3584.0)	543.3 (160.80, 3391.00)	<0.001
LAD (mm)			0.003
LAA (cm^2)			<0.001
LAP (mmHg)			0.568
LVEF (%)			0.070

NT-pro BNP and Us-CRP were presented as median (interquartile range); other characteristics were presented as . The difference in gender and smoking was analyzed by chi-square tests; AF: atrial fibrillation; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HT: hypertension; HLP: hyperlipidemia; DM: diabetes mellitus; CHD: coronary heart disease; ACEI: angiotensin-converting enzyme inhibitors; ARB: angiotensin receptor blocker; CCB: calcium channel blocker; HbAlc: hemoglobin A1c; Cr: creatinine; TC: total cholesterol; TG: triglycerides; LDL: low-density lipoprotein; HDL: high-density lipoprotein; Us-CRP: ultrasensitive C-reaction protein; NT-proBNP: N-Terminal probrain natriuretic peptide; LAD: left atrial diameter; LAA: left atrial area; LAP: left atrial pressure; LVEF: left ventricular ejection fraction. .